– June 2017 MiFid II McKinsey&Company
Algosun Global Limited maintains a Conflict of Interest Policy and has no principal conflicts associated with investment banks – broker-dealing, proprietary trading, corporate finance, corporate broking, or portfolio management activities. The Director of Research is the firm’s designated Compliance Officer.
Algosun Global Limited is a provider of equity research, consulting, and market analysis services. Algosun Global Limited is not a registered broker-dealer or an investment adviser with Cyprus Securities and Exchange Commission (hereinafter “CySec”) or with any state securities regulatory authority. This Policy sets out rules on how we aim to manage conflicts of interest in our business in a consistent manner.
Conflicts of interest would involve situations where:
There cannot be a conflict of interest unless there is a potential for a client to suffer some form of loss. For this Policy, a client includes:
We are taking all reasonable steps to prevent conflicts of interest from constituting or giving rise to a material risk of damage to the interests of our clients. These cover:
All employees require Compliance Officer approval before executing transactions in listed securities for their account, and transactions in securities of public companies covered by Algosun Global Limited research are not permitted. The firm must not act on any research advice for its benefit, where the client's interests are always prioritized.
Analysts, researchers, and any other employees involved in the production of equity research must not accept inducements from those interested in equity research. Small gifts or minor hospitality are not deemed inducements; however, analysts and researchers are not permitted to accept inducements above the level set out in the firm’s Internal Gifts Policy. All gifts must be notified to Compliance Officer using the appropriate form.
Analyst and researcher performance-related pay is based solely on the accuracy and quality of their stock ratings and not on the performance of any other groups other than the firm. No part of the analyst’s and researcher’s remuneration is related directly or indirectly to the views expressed in the research reports. Analysts and researchers are not permitted to accept any remuneration or other benefit from any party in respect of the publication of research.
Analysts and researchers may not serve as officers, directors, employees, or advisors to a company under research coverage. Employment or the acceptance of directorships outside the company by our employees is subject to approval by Compliance. All personnel, including analysts, must declare all outside business interests to keep Algosun Global Limited informed of any apparent appearance of or actual conflicts of interest. Algosun Global Limited is not involved in sponsored research, namely equity research sponsored by companies under research coverage.
In addition to the conflicts above, there are additional potential conflicts relating to the work of equity analysts and quantitative researchers. We have adopted procedures to ensure that these are appropriately managed and do not compromise the integrity of our published research. The following points are particularly relevant:
In the unlikely event that we cannot satisfactorily manage a conflict, we shall disclose the conflict to the relevant client and allow it to make an informed decision as to whether to proceed with a proposed transaction.